Purpose: Intra-arterial cisplatin infusion chemotherapy delivers higher concentration of this therapeutic agent to the limited area of cervical carci noma. We evaluated the role of endorectal ultrasonography (ERUS) in the analysis of the tumor response to this chemotherapy.
ERUS in analyzing morphologic response of cerv ical carcinoma to intra -arterial cisplatin chemotherapy after selective internal iliac arteriography.
MATERIALS and METHODS
We pertormed intra -arterial cisplatin infusion chemothe r apy and ERUS in 20 patients , who had been diagnosed and staged as cervical carcinomas by means of gynecological examination , cytology under the colposcopic punch biopsy and other rad iological examinations (CT, MRI , etc.l. The age of these patients ranged from 32 to 60 years (mean age = 51).
Cisplatin (Noksibja Inc. , Seoul , Korea) infusion ch emotherapy (50 mg/m2) through an autoinjector after bilate ral selective internal iliac arteriography was done twice with 3 week interval using the 7 -F torque • control l ed balloon catheter (Cordis Co. , Miami , Florida , USA). AII patients underwent radical hysterectomy and Iymphadenectomy on the sixth week after initial intraarterial chemotherapy ERUS was performed with the patient on left lateral decubitus knee -chest position and also with the patient in a medium bladder -relaxation condition (because excessive bladder distension affects pelvic organs and causes difficulties in carrying out the examination). We used 5 MHz longitudinallinear array transducer (SL -2, Siemens , Erlangen , Germany) covered with jelly -filled rubber bag. Along the reference sagittal plane(Oo) in the middle of uterine cervix and vagina , we moved and rotated the transducer (until right or left 65 0 -70 0 ) to evaluate the uterus , uterine cervix , vagina and parametrium . We comparatively examined the size (measuring the largest anterior-posterior and longitudinal diameters) and sonographic morphology of the tumor before , during and after intra -arterial cisplatin infusion , in each patien t. We measured both the anteriorposterior and longitudinal diameters of the uterine cervical carcinomas that were scanned as the largest ones on ERUS. So the tumor area reduction rate ( %) was calculated as follows : 100 -[ (AP diameter X longitudinal diameter of the preoperative tumor)1 (AP diameter X longitudinal diameter of the initial tumor) l. The findings of ERUS were evaluated according to the consensus of two radiologists who were blinded to the findings of colposcopy and operative pathology.
ERUS findings were compared with those of colposcopy and surgical pathology. We used SPSS (Statistical Package for the Social Sciences) to obtain pearson 's correlation coefficiency between tumor size and findings of gaseous necrosis on preopera tive ERUS with operative and pathologic findings
RESULTS
The clinicopathologic and ERUS findings in 20 patients of cervical carcinomas were summarized in Table 1 . There were 5 Stage Ib , 7 lI a, 6 IIb , and 2 IIla cervical carcinomas.
Comparing the normal ERUS anatomy of uterine cervix( Fig . 1) , all cervical carcinomas (before , during and after chemotherapy) in 20 patients could be detected through scrutinizing evaluation of ERUS. The tumors were usually hypoechoic and ill-defined , but they could be differentiated from surrounding normal cervi- cal stroma or parametrium (Fig. 2) . Cervical carcinoma occasionally appear as a 10cal lesion (hypoechoic, hyperechoic, or mixed) distinct 1rom the normal cervical stroma (35 % 01cases , Fig. 3, 4) . The ERUS 1indings such as the size and morphology 。 1 the 1umor just be10re the operation correlated well with operative and pathologic 1indings in each patient (r 2 in tumor size = 0.99 , r 2 in gaseous necrosis 014 cases = 1).
Tumor reduction rates after the chemotherapy were more than 75 % decrease 01 the original size in 3 patients (Fig. 1 c) , 50% -75 % in 6 patients , 25% -50 % in 8 patients (Fig. 2b & 3b) , and less than 25% in 3 patients. The preoperative tumor size on ERUS correlated well with that 01 surgical pathology in all patients.
Originally hypoechoic tumor on ERUS changed into mixed echoic tumors in 3 patients.
Small hyperechoic re11ecting areas were noted during the intra -arterial chemoin1usion procedures in 4 patients (Fig. 3b) , which corresponded to areas 01 gaseous necrosis on colposcopic and postoperative pathology.
DISCUSSION
Intra -arterial in1usion chemotherapy using balloon catheter after selective internal il iac arteriography delivers a highly concentrated therapeutic agent to a lim ited anatomical area than the conventional intravenous approach. The selective balloon occlusion 01 arteries can increase the concentration 01 the agent to the tumor 1eeding vessels and decrease complications in adjacent non tumor -bearing areas. The dose 0150 mg/ m 2 cisplatin was considered to be the highest concentration 01 this effective regimen tolerable to the patients. Carson et al. (2) reported that i ntra -arterial noma 01 the uterine cervix with constant i ntra -arteri al 카 cisplatin infusion. They used constant internal iliac artery infusion of CDDP via an implant chemotherapy pump with or without standard external and interstitial radiotherapy in 12 advanced and recurrent squamous cervical carcinoma patients , and 6 patients (67 % ) were disease -free (at 12 to 60 weeks) among 9 fOllow -up patients. They concluded that the results of concurrent intraarterial infusion of cisplatin and standard radiotherapy were encouraging(3). Scarabelli et al. (4) reported that they achieved an overall objective rea sponse rate of 84 % in locally advanced and recurrent cervical carcinomas by a bilateral sequential infusion of cisplatin , peptichemio and doxorubicin in a 6 -hour period via an external infusion pump. In our study , all 20 cervical carcinomas showed decrease of tumor size of variable degree after two times of intra -arterial cisplatin infusion chemotherapy. So it seems that intra arterial cisplatin infusion chemotherapy after selective internal iliac arteriography is an effective preoperative therapy in uterine cervical carcinomas limited to the Computed tomography(CT) has been widely used to detect and stage the cervical carcinom a. Even though it has merits to detect Iymph nodes and metastasis, sometimes it cannot visualize the isodense tumor that does not enhance differentially in surrounding normal cervical stroma. CT has demonstrated a low accuracy rate in evaluation of parametrial involvement, ranging from 30% to 50% (13 -15) . Magnetic resonance imaging is now known to be the most accurate method in diagnosis and staging of cervical carcinomas (16 , 17), but the cost of it is still high , so it is not convenient to use MRI repeatedly as frequent routine follow -up study in the same patient.
Since the diagnostic application of ERUS to the cervical carcinoma by Zaritzky(7) , ERUS has been used to visualize the uterine cervix and parametrial tissue and to estimate the extent, local staging , and recurrence of cervical carcinoma (8) (9) (10) (11) (12) . ERUS depicts not only the tumor itself in uterine cervix but also its parametrial invasion pattern (8) (9) (10) (11) (12) . This noninvasive , low -cost ERUS can be performed easily and repeatedly in shortertime without radiation hazard or motion artifact. ERUS is a convenient imaging method of cervical carcinomas following intra -arterial cisplatin infusion chemotherapy , although it has limitations to detect Iymphadenopathy or distant metastasis. We may conclude that ERUS can play an important role in the analysis of morphologic change responding to intra -arterial cisplatin infusion chemotherapy after selective internal il iac arteriography. 
